MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
-
* Corresponding authors: Carlos Caldas cc234@cam.ac.uk - Eric A Miska eam29@cam.ac.uk
- Equal contributors
Genome Biology 2007, 8:R214 doi:10.1186/gb-2007-8-10-r214
Accesses
- Last 30 days: 421 accesses
- Last year: 4634 accesses
- All time: 26013 accesses
Cited by
BioMed Central: 18 citations
|
Pair-barcode high-throughput sequencing for large-scale multiplexed sample analysis Jing Tu, Qinyu Ge, Shengqin Wang, Lei Wang, Beili Sun, Qi Yang, Yunfei Bai, Zuhong Lu BMC Genomics 2012, 13:43 (25 January 2012) |
|
Shyh-Dar Li, Tatsuaki Tagami, Ying-Fu Ho, Chen-Hsiang Yeang BMC Systems Biology 2011, 5:186 (4 November 2011) |
|
Yan Jiao, Katherine Lawler, Gargi S Patel, Arnie Purushotham, Annette F Jones, Anita Grigoriadis, Andrew Tutt, Tony Ng, Andrew E Teschendorff BMC Bioinformatics 2011, 12:403 (19 October 2011) |
|
Min Zhu, Ming Yi, Chang Hee Kim, Chuxia Deng, Yi Li, Daniel Medina, Robert M Stephens, Jeffrey E Green Genome Biology 2011, 12:R77 (16 August 2011) Expression profiling in mouse models of mammary tumors identifies miRNA signatures particular to lineages or driver oncogenes
|
|
New miRNA labeling method for bead-based quantification Alberto Biscontin, Silvia Casara, Stefano Cagnin, Lucia Tombolan, Angelo Rosolen, Gerolamo Lanfranchi, Cristiano De Pittà BMC Molecular Biology 2010, 11:44 (16 June 2010) |
|
MicroRNAs and their target gene networks in breast cancer Elizabeth O'Day, Ashish Lal Breast Cancer Research 2010, 12:201 (19 March 2010) |
|
Characterisation of microRNA expression in post-natal mouse mammary gland development Stefanie Avril-Sassen, Leonard D Goldstein, John Stingl, Cherie Blenkiron, John Le Quesne, Inmaculada Spiteri, Konstantina Karagavriilidou, Christine J Watson, Simon Tavaré, Eric A Miska, Carlos Caldas BMC Genomics 2009, 10:548 (20 November 2009) |
|
Chao Cheng, Xuping Fu, Pedro Alves, Mark Gerstein Genome Biology 2009, 10:R90 (1 September 2009) Most microRNAs have a stronger inhibitory effect in estrogen receptor-negative than in estrogen receptor-positive breast cancers |
|
MicroRNA expression profiling of male breast cancer Matteo Fassan, Raffaele Baffa, Juan P Palazzo, Joshua Lloyd, Marco Crosariol, Chang-Gong Liu, Stefano Volinia, Hannes Alder, Massimo Rugge, Carlo M Croce, Anne Rosenberg Breast Cancer Research 2009, 11:R58 (10 August 2009) |
|
Sanne Nygaard, Anders Jacobsen, Morten Lindow, Jens Eriksen, Eva Balslev, Henrik Flyger, Niels Tolstrup, Søren Møller, Anders Krogh, Thomas Litman BMC Medical Genomics 2009, 2:35 (9 June 2009) Analysis of breast cancer and adjacent tissue using deep-sequencing technology and a novel computational pipeline identifies 5 new microRNAs, and indicates that sequence end variability may be used as a discriminatory feature to aid future microRNA discovery.
|
|
Aoife J Lowery, Nicola Miller, Amanda Devaney, Roisin E McNeill, Pamela A Davoren, Christophe Lemetre, Vladimir Benes, Sabine Schmidt, Jonathon Blake, Graham Ball, Michael J Kerin Breast Cancer Research 2009, 11:R27 (11 May 2009) |
|
Identification and characterization of new miRNAs cloned from normal mouse mammary gland Nezha Sdassi, Licia Silveri, Johann Laubier, Gaëlle Tilly, José Costa, Sarah Layani, Jean-Luc Vilotte, Fabienne Le Provost BMC Genomics 2009, 10:149 (7 April 2009) |
|
Finding microRNA regulatory modules in human genome using rule induction Dang Tran, Kenji Satou, Tu Ho BMC Bioinformatics 2008, 9(Suppl 12):S5 (12 December 2008) |
|
Christina N Bennett, Jeffrey E Green Breast Cancer Research 2008, 10:213 (11 September 2008) |
|
PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes Anna Git, Inmaculada Spiteri, Cherie Blenkiron, Mark J Dunning, Jessica CM Pole, Suet-Feung Chin, Yanzhong Wang, James Smith, Frederick J Livesey, Carlos Caldas Breast Cancer Research 2008, 10:R54 (27 June 2008) Breast cancer cell line PMC42 is a good model for normal breast epithelium, providing a unique biological tool to study breast differentiation and the function of key miRNAs typically lost in cancer.
|
|
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer Grace M Callagy, Mark J Webber, Paul DP Pharoah, Carlos Caldas BMC Cancer 2008, 8:153 (29 May 2008) |
|
Elizabeth M Azzato, Kristy E Driver, Fabienne Lesueur, Mitul Shah, David Greenberg, Douglas F Easton, Andrew E Teschendorff, Carlos Caldas, Neil E Caporaso, Paul DP Pharoah Breast Cancer Research 2008, 10:R47 (28 May 2008) |
|
Reasons for breast cancer heterogeneity François Bertucci, Daniel Birnbaum Journal of Biology 2008, 7:6 (22 February 2008) |